Neuraxpharm launches European campaign to increase awareness of medical cannabis
Neuraxpharm launches European campaign to increase awareness of medical cannabis
On the occasion of the German Pain Congress 2022 (Deutscher Schmerzkongress 2022) the CNS-specialist announces Change for Health campaign
Düsseldorf and Barcelona, October 19, 2022 – Neuraxpharm, a leading European specialty pharmaceutical company, today announces its “Change for Health” campaign that aims to increase the acceptance of medical cannabis and provide better information to patients, physicians and pharmacies.
